By Mitul Agarwal, B.Pharm, MBA. Published October 2026.
In pharma, API stands for Active Pharmaceutical Ingredient: the substance in a medicine that produces its therapeutic effect. In a paracetamol 500 mg tablet, the 500 mg of paracetamol is the API, and everything else in the tablet is an excipient. APIs are made in specialised plants, sold by the kilogram to the companies that turn them into finished medicines, and must meet a pharmacopoeia or in-house specification under GMP.
Outside pharma, API usually means "application programming interface", a software term. If that is what you were looking for, this is the wrong page. If you work with medicines, read on, because the API is where quality, cost and supply security are largely decided.
One ingredient, several names
You will meet the same material under different names depending on who is talking. Regulators and ICH guidelines usually say drug substance, which is the term used in registration dossiers. In India it is widely called a bulk drug, including in government schemes and trade statistics. EU legislation speaks of the active substance. All of them describe the same thing; our explainer on drug substance versus drug product sets out how it differs from the finished medicine.
The API and everything around it
A medicine contains two kinds of ingredient. The API gives the effect: atorvastatin lowers cholesterol, amoxicillin kills bacteria. The excipients make the medicine work as a product. Fillers such as microcrystalline cellulose or lactose give a tablet its bulk, binders hold it together, disintegrants help it break apart in the body, lubricants such as magnesium stearate stop it sticking to the machines, coatings protect it, and buffers and preservatives keep a liquid stable.
The balance between the two varies enormously. A metformin 1,000 mg tablet is mostly API. A 25 microgram levothyroxine tablet is almost entirely excipient, which is one reason low-dose products are so demanding to make consistently.
Where the API sits in the supply chain
Every API has a history before it reaches a formulation plant. Production begins with a key starting material (KSM), the building block from which the registered process starts. That material passes through a series of intermediates as the molecule is built step by step. The final reaction and purification give the API, which is tested and released. Only then does it travel to a formulation plant to become a finished dosage form: tablets, capsules, injections and so on. Our checklist for sourcing finished formulations picks up the story from there.
How APIs are made
Most small-molecule APIs, such as paracetamol, metformin and atorvastatin, are made by chemical synthesis. Many antibiotics and their precursors come from fermentation; penicillin G, the starting point for the semi-synthetic penicillins, is a good example. Some APIs are extracted from plant or animal sources, as with certain alkaloids and heparin. Proteins such as insulin and monoclonal antibodies are made in living cells using biotechnology. These are usually called biological drug substances rather than APIs, but they play the same role.
A subset of APIs, known as high-potency APIs (HPAPIs), are active at very low doses. Many cancer drugs and some hormones fall into this group, and they need contained plants and specialised handling. Our guide to top CDMOs for small-molecule APIs looks at who makes them.
Grades and specifications
An API is bought against a specification, usually a pharmacopoeia monograph: the Indian (IP), British (BP), European (Ph. Eur.), United States (USP) or Japanese (JP) pharmacopoeia. Where no monograph exists, the manufacturer's in-house specification applies. Whichever it is, your RFQ should name the grade your dossier is built on. The specification will cover identity, assay, related substances (impurities) and residual solvents, and where relevant particle size, polymorph and microbial limits.
Many APIs are also salts, such as metformin hydrochloride, and the exact salt and hydrate have to match the dossier too. Our explainer on hydrochloride versus base explains why.
The paperwork that travels with an API
A serious API supplier should be able to give you a Certificate of Analysis for every batch and a GMP certificate for the manufacturing site, issued by the national regulator or following an EU, US or WHO inspection. Behind those sits a regulatory file: a US DMF, a CEP (issued by EDQM) or an ASMF, which has an open part shared with the buyer and a restricted part sent only to the regulator, or the local equivalent.
Two further documents depend on where the API is going. APIs exported to the EU need a written confirmation from the exporting country's regulator that the site follows GMP equivalent to EU standards, unless the country is on the EU's equivalence list. And many countries register the foreign API maker before import: in India, for example, an imported API needs a registration certificate (Form 41) for the overseas manufacturer and an import licence (Form 10) for the importer.
Our supplier verification guide shows how to check each of these documents for yourself.
India, China and supply security
India and China are the world's two largest sources of generic APIs. India exports APIs and finished generics on a very large scale, but it has long relied on China for a significant share of its key starting materials and intermediates. To reduce that dependence, India launched a production-linked incentive (PLI) scheme in 2020 with an outlay of ₹6,940 crore for 41 critical bulk drug products: KSMs, drug intermediates and APIs. Production has since started for several products that were previously imported, including penicillin G and clavulanic acid.
For a buyer, the lesson is practical. When supply security matters, ask where the KSM comes from, not just where the API is made.
How PharmaTradz can help
Tell us the API, the grade, the salt form, the quantity and the documents you need, whether DMF, CEP, CoA or GMP certificate. We match you with manufacturers and share their document status before you commit. Send us an RFQ, or if you make APIs yourself, list your products to reach buyers. If you are thinking of importing medicines rather than ingredients, our guide on how to start a pharmaceutical import business is a good next read, and our six-language pharma glossary explains the rest of the vocabulary.
Frequently Asked Questions(FAQs)
What is the full form of API in pharma?
API stands for Active Pharmaceutical Ingredient: the substance in a medicine that produces its therapeutic effect. It is also called the drug substance, or a bulk drug in India.
What is an example of an API?
Paracetamol in a paracetamol tablet, amoxicillin in an amoxicillin capsule and metformin hydrochloride in a metformin tablet are all APIs.
What is the difference between an API and an excipient?
The API gives the medicine its effect. Excipients, such as fillers, binders, lubricants and coatings, turn the API into a usable, stable dosage form but have no intended therapeutic effect of their own.
What is the difference between an API and an intermediate?
An intermediate is a compound made partway through the synthesis. The API is the final active substance after the last reaction and purification steps, tested and released for use in medicines.
What documents should come with an API purchase?
A Certificate of Analysis for each batch, the site's GMP certificate and a regulatory file such as a DMF, CEP or ASMF. For the EU, a written confirmation from the exporting country's regulator is also needed, unless that country is on the EU's equivalence list.
